{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:56:07Z","timestamp":1785419767645,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jad-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jad.2012.08.042","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T02:45:45Z","timestamp":1348541145000},"page":"79-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The prevalence of metabolic syndrome in drug-na\u00efve bipolar II disorder patients before and after twelve week pharmacological intervention"],"prefix":"10.1016","volume":"146","author":[{"given":"Mei","family":"Hung Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Hua Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-Sheng","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei-Ru","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin","family":"Chun Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Kuang Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Band","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po","family":"See Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2012.08.042_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000065414","article-title":"Weight gain and serum leptin levels in patients on lithium treatment","volume":"46","author":"Atmaca","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2012.08.042_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000067809","article-title":"Serum leptin and cholesterol levels in patients with bipolar disorder","volume":"46","author":"Atmaca","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2012.08.042_bib3","first-page":"75","article-title":"Bipolar disorder and metabolic syndrome: comorbidity or side effects of treatment of bipolar disorder","volume":"22","author":"Babic","year":"2010","journal-title":"Psychiatria Danubina"},{"key":"10.1016\/j.jad.2012.08.042_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2010.11.020","article-title":"Differences between bipolar I and bipolar II disorders in clinical features, comorbidity, and family history","volume":"131","author":"Baek","year":"2011","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.08.042_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.eurpsy.2007.10.007","article-title":"Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists","volume":"23","author":"Bauer","year":"2008","journal-title":"European Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex maintenance study group","volume":"57","author":"Bowden","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jad.2008.12.018","article-title":"High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan","volume":"117","author":"Chang","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.08.042_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JCP.0b013e3181f03f50","article-title":"C825T polymorphism of the GNB3 gene on valproate-related metabolic abnormalities in bipolar disorder patients","volume":"30","author":"Chang","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.08.042_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jad.2009.12.011","article-title":"The role of valproate in metabolic disturbances in bipolar disorder patients","volume":"124","author":"Chang","year":"2010","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.08.042_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1399-5618.2009.00771.x","article-title":"Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1","volume":"12","author":"Chang","year":"2010","journal-title":"Bipolar Disorder"},{"key":"10.1016\/j.jad.2012.08.042_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuroimage.2007.11.007","article-title":"Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers\u2014a SPECT study","volume":"40","author":"Chen","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.jad.2012.08.042_bib12","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.neuroimage.2010.10.082","article-title":"Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers\u2014a SPECT study","volume":"56","author":"Chen","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.jad.2012.08.042_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00048670802534341","article-title":"Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls","volume":"43","author":"Elmslie","year":"2009","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-5618.2005.00234.x","article-title":"Metabolic syndrome in bipolar disorder: findings from the bipolar disorder center for Pennsylvanians","volume":"7","author":"Fagiolini","year":"2005","journal-title":"Bipolar Disorder"},{"key":"10.1016\/j.jad.2012.08.042_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10401230802177722","article-title":"Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder","volume":"20","author":"Fiedorowicz","year":"2008","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000092219","article-title":"Atypical antipsychotic usage-related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patients","volume":"53","author":"Gergerlioglu","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2012.08.042_bib17","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jpsychires.2011.03.010","article-title":"Co-occurring manic symptomatology influences HPA axis alterations in depression","volume":"45","author":"Jabben","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jad.2012.08.042_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1399-5618.2010.00823.x","article-title":"Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine\/metabolic system and treatment outcome","volume":"12","author":"Kemp","year":"2010","journal-title":"Bipolar Disorder"},{"key":"10.1016\/j.jad.2012.08.042_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/10673220902899722","article-title":"Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment","volume":"17","author":"Kenna","year":"2009","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1399-5618.2004.00138.x","article-title":"Burden of general medical conditions among individuals with bipolar disorder","volume":"6","author":"Kilbourne","year":"2004","journal-title":"Bipolar Disorder"},{"key":"10.1016\/j.jad.2012.08.042_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-2850.2008.00106.x","article-title":"Understanding the relation between obesity and depression: causal mechanisms and implications for treatment","volume":"15","author":"Markowitz","year":"2008","journal-title":"Clinical Psychology\u2014Science and Practice"},{"key":"10.1016\/j.jad.2012.08.042_bib22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4088\/JCP.v65n0507","article-title":"Are mood disorders and obesity related? A review for the mental health professional","volume":"65","author":"McElroy","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2010.04.012","article-title":"Bipolar disorder and metabolic syndrome: an international perspective","volume":"126","author":"McIntyre","year":"2010","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.08.042_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.jcp.0000085403.08426.f4","article-title":"Antipsychotic-induced weight gain: bipolar disorder and leptin","volume":"23","author":"McIntyre","year":"2003","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.08.042_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0269881105058678","article-title":"Metabolism, lifestyle and bipolar affective disorder","volume":"19","author":"Morriss","year":"2005","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jad.2012.08.042_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0165-0327(02)00363-4","article-title":"Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use","volume":"73","author":"Regenold","year":"2003","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.08.042_bib27","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2174\/092986707782360088","article-title":"Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review","volume":"14","author":"Reynolds","year":"2007","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.jad.2012.08.042_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jad.2011.10.025","article-title":"Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study","volume":"136","author":"Salvi","year":"2012","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.08.042_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1399-5618.2008.00599.x","article-title":"Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database","volume":"10","author":"Sicras","year":"2008","journal-title":"Bipolar Disorder"},{"key":"10.1016\/j.jad.2012.08.042_bib30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archpsyc.63.7.824","article-title":"Association between obesity and psychiatric disorders in the US adult population","volume":"63","author":"Simon","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib31","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4088\/JCP.10m06068yel","article-title":"Increased systemic cortisol metabolism in patients with schizophrenia and bipolar disorder: a mechanism for increased stress vulnerability?","volume":"72","author":"Steen","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-0327(90)90088-P","article-title":"Albumin decrement in depression and cholesterol decrement in mania","volume":"19","author":"Swartz","year":"1990","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.08.042_bib33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4088\/JCP.v67n0704","article-title":"Association between bipolar disorder and metabolic syndrome: a review","volume":"67","author":"Taylor","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1192\/bjp.bp.109.074674","article-title":"Effects of severe mental illness on survival of people with diabetes","volume":"197","author":"Vinogradova","year":"2010","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.08.042_bib35","first-page":"613","article-title":"Depressive symptoms, cortisol, visceral fat and metabolic syndrome","volume":"53","author":"Vogelzangs","year":"2011","journal-title":"Tijdschrift Voor Psychiatrie"},{"key":"10.1016\/j.jad.2012.08.042_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2006.08.009","article-title":"Atypical antipsychotics related metabolic syndrome in bipolar patients","volume":"98","author":"Yumru","year":"2007","journal-title":"Journal of Affective Disorders"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712006131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712006131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T22:59:50Z","timestamp":1687733990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032712006131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0165032712006131"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.08.042","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence of metabolic syndrome in drug-na\u00efve bipolar II disorder patients before and after twelve week pharmacological intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2012.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}